Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Price To Book Ratio

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.

The item "Price-To-Book-Ratio" stands at 2.37 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Price To Book Ratio" stands at 2.37. This represents an increase of 5.46 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.32 percent compared to the value the year prior.
The 1 year change in percent is 9.32.
The 3 year change in percent is 320.25.

The Serie's long term average value is 1.12. It's latest available value, on 09/30/2025, is 110.90 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +358.03%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Price To Book Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Book Ratio905,699,262,464.00
LogoJohnson & Johnson - Price To Book Ratio486,508,953,600.00
LogoAbbVie Inc - Price To Book Ratio399,570,305,024.00
LogoRoche Holding AG - Price To Book Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price To Book Ratio280,205,508,085.11